307. Rational Development of 12 Different AAV Serotypes as Scaffolds for Peptide Display
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33916-8
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV